Search

everythinglearnresearchcommunity

for

Search:↓

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The link between anabolic agents and colorectal cancer risk is unclear.

Male mice with FGF5 mutations grow longer hair than females.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Dexamethasone may influence hair growth by altering estrogen receptor activity in hair cells.

δ-GABAA receptors affect alcohol consumption based on the estrous cycle and influence movement regardless of the cycle.

Testosterone protects female heart cells from stress by activating estrogen receptors.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Caffeine may help reduce stress-induced hair loss.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

The European School of Oncology organized various educational events in 1994, highlighting important cancer research findings.

Taking tamsulosin or finasteride and being older increase the risk of floppy iris during cataract surgery.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

Hormonal contraceptives and related compounds can increase health risks like thrombosis and affect sexual function.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

The formulation significantly increased hair density and thickness safely in people with androgenetic alopecia.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Prolactin may influence skin glands and could be a target for treating acne and skin aging.

SSRIs may help manage sexual behavior in dementia patients, but they can cause long-lasting sexual dysfunction.

A new compound effectively inhibits human 5α-reductase 1.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.